-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

621.O3.6 621. Lymphomas: Translational—Molecular and Genetic: Functional Genomics and Biology

Symposia: Lymphomas: Translational—Molecular and Genetic Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, apoptosis, Translational Research, Lymphomas, non-Hodgkin lymphoma, CHIP, assays, genomics, bioinformatics, B Cell lymphoma, T Cell lymphoma, Diseases, immune mechanism, Therapies, immunology, aggressive lymphoma, Lymphoid Malignancies, metabolism, Biological Processes, Technology and Procedures, molecular biology, profiling, pathogenesis, molecular testing, omics technologies
Monday, December 12, 2022: 2:45 PM-4:15 PM
388-390 (Ernest N. Morial Convention Center)
Moderators:
Roberto Chiarle, MD, Children's Hospital Boston and Wendy Béguelin, PhD, Weill Cornell Medicine
Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Qurat Ul Ain Qureshi, BSc1*, Krysta M. Coyle, PhD1, Nicole Thomas1, Brett Collinge2*, Kostiantyn Dreval3*, David W. Scott, PhD, MD, FRACP, FRCPA2,4, Timothy E Audas, PhD1* and Ryan D. Morin3,5

1Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, BC, Canada
2Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, BC, Canada
3Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada
4Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
5Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada

3:00 PM

Katrin Pansy1*, Karoline Fechter2*, Kerstin Wenzl, PhD3, Aditya Arra4*, Joseph P. Novak3*, Marta Szmyra2*, Sandra Haingartner2*, Alan G. Ramsay, BSc, MSc, PhD5, Anne J. Novak, PhD3, Hildegard T. Greinix, MD2, Christine Beham-Schmid6*, Peter Neumeister, MD1* and Alexander J.A. Deutsch1*

1Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
2Division of Hematology, Medical University of Graz, Graz, Austria
3Division of Hematology, Mayo Clinic, Rochester, MN
4Clinic for Experimental Pedriatics, Otto-von-Guericke-Universität Magdeburg, Magdeburg, Germany
5Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom
6Institute of Pathology, Medical University of Graz, Graz, Austria

3:15 PM

Dylan T. Jochum, BS1, Waseem G. Lone, Ph.D.1*, Alyssa C. Bouska, Ph.D.1*, Xuxiang Liu, PhD2*, Jiayu Yu, PhD1*, Catalina Amador, MD3*, Sunandini Sharma1*, Tyler A. Herek, PhD1, Wing C. Chan, MD2 and Javeed Iqbal, Ph.D.1*

1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
2Department of Pathology, City of Hope National Medical Center, Duarte, CA
3University of Miami Miller School of Medicine, Miami, FL

3:30 PM

Yu Y. Li, BS1,2*, Lauren C. Chong1*, Bruce W Woolcock1*, Adèle Telenius1*, Susana Ben-Neriah, MSc1*, Graham W Slack, MD, PhD1,2*, Vivian Lam3*, Aixiang Jiang, MSc1*, Elena Viganò, PhD1, Tomohiro Aoki, MD, PhD1, Shannon Healy, PhD1*, Gerald Krystal, PhD3*, Leandro Venturutti, PhD, MSc1,2,3*, David W. Scott, PhD, MD, FRACP, FRCPA1 and Christian Steidl, MD1,2

1Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
3Terry Fox Laboratory, BC Cancer, Vancouver, BC, Canada

3:45 PM

Salomé Decombis1*, Celine Bellanger1*, Yannick LE Bris, PhD, PharmD1,2*, Delphine Boulet, PhD1*, Jane Jardine, PhD1*, Christelle Dousset1*, Audrey Ménard2*, Charlotte Kervoelen, PhD3*, Elise Douillard1*, Philippe Moreau, MD1,4*, Stephane Minvielle, PhD1*, Agnes Moreau-Aubry, PhD1*, Benoit Tessoulin, MD1,5*, Nicolas Bidère, PhD1*, Steven Le Gouill, MD, PhD6, Catherine Pellat-Deceunynck, PhD1 and David Chiron, PhD1*

1CRCI2NA, Integrated Research Center in Immunology and Oncology, Nantes University, Nantes, France
2Department of Biological Hematology, CHU Nantes, Nantes, France
3Therassay (Onco-Hemato) Core Facility, Nantes Université, Capacités, Nantes, France
4Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
5Hematology Department, Nantes University Hospital, Nantes, France
6Institut Curie, Paris, Paris, France

4:00 PM

Carine Jaafar, PhD1*, Purushoth Ethiraj, PhD1*, Zhijun Qiu, PhD1*, An-Ping Lin1* and Ricardo Aguiar, MD, PhD2

1University of Texas Health Science Center, San Antonio, TX
2University of Texas Health Sci. Ctr., San Antonio, TX

*signifies non-member of ASH